The DOI matches its Crossref record; 8 of the 9 references it cites were found in a registry or an index.
The Phosphoinositide 3-Kinase Pathway
Abstract
Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components. The role of phosphoinositide 3-kinase (PI3K), which catalyzes the production of phosphatidylinositol-3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metabolism; and cytoskeletal rearrangements are highlighted. The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapuetic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of phosphoinositide-3-kinase (PI3K) by ligation of growth factors to their cellular receptors promotes recruitment of Akt to the plasma membrane and its subsequent activation 28.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [28]
Citations
Cites
Fruman, D. A., Meyers, R. E., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,382
Self-citationBrunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,208
Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,068
Regulation of C. elegans Life-Span by Insulinlike Signaling in the Nervous System
Wolkow, C. A., Kimura, K. D., Lee, M. S., & Ruvkun, G. (2000) · Science · doi:10.1126/science.290.5489.147 · Cited by 681
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 599
Clark, A. S., West, K. A., Streicher, S. A., & Dennis, P. A. (2002) · PubMed · Cited by 589
The lipid phosphatase SHIP2 controls insulin sensitivity
Clément, S., Krause, U., Desmedt, F., Tanti, J., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J. M., Doherty, M., Malaisse, W. J., et al. (2001) · Nature · doi:10.1038/35051094 · Cited by 377
Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival
Liu, D., Xiao-hong, Y., & Songyang, Z. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00733-8 · Cited by 135
Flagged first, then by citations
1 of the 9 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,027
The Redox Regulation of PI 3-Kinase–Dependent Signaling
Leslie, N. R. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1765 · Cited by 151
Shishodia, S., Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.026 · Cited by 149
Subramanian, S., West, R. B., Corless, C. L., Ou, W., Rubin, B. P., Chu, K., Leung, S. Y., Yuen, S. T., Zhu, S., Hernandez‐Boussard, T., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208056 · Cited by 149
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells
Khan, M. N., Maryam, A., Qazi, J. I., & Ma, T. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.11595 · Cited by 148
Storm, M. P., Bone, H. K., Beck, C. G., Bourillot, P.-Y., Schreiber, V., Damiano, T., Nelson, A. S., Savatier, P., & Welham, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610906200 · Cited by 147
Na+,K+-ATPase as a docking station: protein–protein complexes of the Na+,K+-ATPase
Reinhard, L., Tidow, H., Clausen, M. V., & Nissen, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1039-9 · Cited by 147
Daniels, M., Lurkin, I., Pauli, R., Erbstößer, E., Hildebrandt, U., Hellwig, K., Zschille, U., Lüders, P., Krüger, G., Knolle, J., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.029 · Cited by 147
Zhao, Y., Liu, J., Cheng, X., Bai, X., & Rui-chao, L. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.12.014 · Cited by 147
Energy metabolism of white adipose tissue and insulin resistance in humans
Bódis, K. B., & Roden, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13017 · Cited by 156
Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.
Sawyer, C., Sturge, J., Bennett, D. C., O’Hare, M. J., Allen, W. E., Bain, J., Jones, G. E., & Vanhaesebroeck, B. (2003) · PubMed · Cited by 147
Um, M., Gross, A. W., & Lodish, H. F. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.08.014 · Cited by 146
Xia, W., Husain, I., Liu, L.-H., Bacus, S. S., Saini, S., Spohn, J., Pry, K. J., Westlund, R. E., Stein, S. H., & Spector, N. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2101 · Cited by 147
SIRT6 in DNA repair, metabolism and ageing
Lombard, D. B., Schwer, B., Alt, F. W., & Mostoslavsky, R. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01902.x · Cited by 148
Hypomorphic Mutation of PDK1 Suppresses Tumorigenesis in PTEN+/− Mice
Bayascas, J. R., Leslie, N. R., Parsons, R. E., Fleming, S., & Alessi, D. R. (2005) · Current Biology · doi:10.1016/j.cub.2005.08.066 · Cited by 145
Mi, Y., Xiao, C., Du, Q., Wu, W., Qi, G., & Liu, X. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.022 · Cited by 145
Hayakawa, M., Kaizawa, H., Moritomo, H., Koizumi, T., Ohishi, T., Yamano, M., Okada, M., Ohta, M., Tsukamoto, S., Raynaud, F. I., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.032 · Cited by 145
Basile, J. R., Afkhami, T., & Gutkind, J. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.6889-6898.2005 · Cited by 145
Molecular and Cellular Determinants of Skeletal Muscle Atrophy and Hypertrophy
Sartorelli, V., & Fulco, M. (2004) · Science s STKE · doi:10.1126/stke.2442004re11 · Cited by 155
PIK3CAmutation is predictive of poor survival in patients with colorectal cancer
Kato, S., Iida, S., Higuchi, T., Ishikawa, T., Takagi, Y., Yasuno, M., Enomoto, M., Uetake, H., & Sugihara, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22890 · Cited by 147
Fernandez-Hernando, C. F., József, L., Jenkins, D., Lorenzo, A. D., & Sessa, W. C. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.196394 · Cited by 144
Yip, P. Y. (2015) · PubMed Central · doi:10.3978/j.issn.2218-6751.2015.01.04 · Cited by 144
Cancer-specific mutations in phosphatidylinositol 3-kinase
Vogt, P. K., Kang, S., Elsliger, M., & Gymnopoulos, M. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.05.005 · Cited by 145
Aoki, K., Nakamura, T., Fujikawa, K., & Matsuda, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-10-0904 · Cited by 144
Osborne, C., & Schiff, R. (2003) · Breast · doi:10.1016/s0960-9776(03)00137-1 · Cited by 149
Thyroid Hormone Receptor β1 Acts as a Potent Suppressor of Tumor Invasiveness and Metastasis
Martínez-Iglesias, O. A., Garcı́a-Silva, S., Tenbaum, S. P., Regadera, J., Larcher, F., Paramio, J. M., Vennström, B., & Aranda, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2198 · Cited by 145
Wang, L., Shi, Z., Jiang, C., Liu, X., Chen, Q.-D., Qian, X., Li, D., Ge, X. Q., Wang, X.-F., Liu, L.-Z., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2116 · Cited by 143
Benítez, J. A., Ma, J., D’Antonio, M., Boyer, A. D., Camargo, M. F., Zanca, C., Kelly, S., Khodadadi‐Jamayran, A., Jameson, N. M., Andersen, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15223 · Cited by 147
Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking
Hou, J. C., & Pessin, J. E. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.04.018 · Cited by 143
Yu, X., Rajala, R. V. S., McGinnis, J. F., Li, F., Anderson, R. E., Yan, X., Li, S., Elias, R. V., Knapp, R. R., Zhou, X., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313283200 · Cited by 143
Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
Vilar, E., Pérez-García, J. M., & Tabernero, J. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0905 · Cited by 149
Lindsay, Y. E., McCoull, D., Davidson, L., Leslie, N. R., Fairservice, A., Gray, A., Lucocq, J. M., & Downes, C. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.000133 · Cited by 142
Makker, A., Goel, M. M., Das, V., & Ak, A. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.583955 · Cited by 142
Manna, D., Albanese, A., Park, W. S., & Cho, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703517200 · Cited by 144
Niedermeier, M., Hennessy, B. T., Knight, Z. A., Henneberg, M., Hu, J., Kurtova, A. V., Wierda, W. G., Keating, M. J., Shokat, K. M., & Burger, J. A. (2009) · Blood · doi:10.1182/blood-2008-06-165068 · Cited by 142
Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., Bánkfalvi, Á., Whiteside, T. L., Lang, S., & Brandau, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.25991 · Cited by 142
VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway
Chen, C.-H., Lai, J. M., Chou, T. Y., Chen, C., Su, L., Lee, Y.-C., Cheng, T.-S., Hong, Y., Chou, C.-K., Whang‐Peng, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005052 · Cited by 141
Liu, H., Zhao, G., Zhang, H., & Li-de, S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.008 · Cited by 145
Akt as a therapeutic target in cancer
Steelman, L. S., Stadelman, K. M., Chappell, W. H., Horn, S., Bäsecke, J., Cervello, M., Nicoletti, F., Libra, M., Stivala, F., Martelli, A. M., et al. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1139 · Cited by 145
Jagarlamudi, K., Liu, L., Adhikari, D., Reddy, P., Idahl, A., Ottander, U., Lundin, E., & Liu, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006186 · Cited by 141
Liu, S.-L., Wang, Z.-G., Hu, Y., Xin, Y., Singaram, I., Gorai, S., Zhou, X., Shim, Y., Min, J.-H., Gong, L.-W., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.035 · Cited by 141
Down, K. D., Amour, A., Baldwin, I. T., Cooper, A. W. J., Deakin, A. M., Felton, L. M., Guntrip, S. B., Hardy, C. J., Harrison, Z. A., Jones, K. L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00767 · Cited by 141
PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation
Kita, K., Kimura, T., Nakamura, N., Yoshikawa, H., & Nakano, T. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01209.x · Cited by 140
Sharp, Z. D., & Bartke, A. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.3.293 · Cited by 122
Tosch, V., Rohde, H. M., Tronchère, H., Zanoteli, E., Monroy‐Jaramillo, N., Kretz, C., Dondaine, N., Payrastre, B., Mandel, J., & Laporte, J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl250 · Cited by 150
Chen, Y., Luo, L., Bai, X., Shen, K., Liu, K., Wang, J., & Hu, D. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108259 · Cited by 141
Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy
Meng, X., Zhang, X., Liu, M., Cai, B., He, N., & Wang, Z. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100864 · Cited by 141
Barbieri, C. E., & Pietenpol, J. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.028 · Cited by 146
Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis
Qin, J., Xie, Y., Wang, B., Hoshino, M., Wolff, D. W., Zhao, J., Scofield, M. A., Dowd, F. J., Lin, M.-F., & Tu, Y. (2009) · Oncogene · doi:10.1038/onc.2009.30 · Cited by 139
Posttranslational regulation of Akt in human cancer
Chan, C., Jo, U., Kohrman, A. Q., Rezaeian, A. H., Chou, P.-C., Logothetis, C. J., & Lin, H. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-59 · Cited by 143
Xia, L., Yin, Z., Mao, L., Wang, X., Liu, J., Jiang, X., Zhang, Z., Lin, K., Chang, J., & Fang, B. (2016) · Scientific Reports · doi:10.1038/srep22005 · Cited by 140
Lu, Y., Azad, N., Wang, L., Iyer, A. K. V., Castranova, V., Jiang, B.-H., & Rojanasakul, Y. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0002oc · Cited by 138
Houlton, J., Abumaria, N., Hinkley, S. F. R., & Clarkson, A. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00790 · Cited by 138
Schink, K. O., Raiborg, C., & Stenmark, H. (2013) · BioEssays · doi:10.1002/bies.201300064 · Cited by 150
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane
Baskin, J. M., Wu, X., Christiano, R., Oh, M. S., Schauder, C. M., Gazzerro, E., Messa, M., Baldassari, S., Assereto, S., Biancheri, R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3271 · Cited by 144
Airway smooth muscle: A modulator of airway remodeling in asthma
Lazaar, A. L., & Panettieri, R. A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.06.030 · Cited by 138
Phosphoinositide 3‐kinase controls early and late events in mammalian cell division
García, Z., Kumar, A., Marqués, M., Cortés, I., & Carrera, A. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600967 · Cited by 138
Dong, X.-Y., Chen, C., Sun, X., Guo, P., Vessella, R. L., Wang, R.-X., Chung, L. W. K., Zhou, W., & Dong, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0411 · Cited by 138
Signaling kinases modulated by 4-hydroxynonenal.
Leonarduzzi, G., Robbesyn, F., & Poli, G. (2004) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2004.08.027 · Cited by 143
Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors
Sun, J., Zhang, D., Bae, D.-H., Sahni, S., Jansson, P. J., Zheng, Y., Zhao, Q., Yue, F., Zheng, M., Kovačević, Ž., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt163 · Cited by 140
Sun, Y., Zhang, H., Meng, J., Guo, F., Ren, D., Wu, H., & Jin, X. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111194 · Cited by 137
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents
Ward, S. G. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00078-x · Cited by 139
Abate-Shen, C. T., Shen, M. M., & Gelmann, E. P. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00292.x · Cited by 136
Cancer chemoprevention through the induction of apoptosis by natural compounds
Kuno, T., Tsukamoto, T., Hara, A., & Tanaka, T. (2012) · Journal of Biophysical Chemistry · doi:10.4236/jbpc.2012.32018 · Cited by 136
Miao, B., Skidan, I. N., Yang, J., Lugovskoy, A. A., Reibarkh, M., Long, K., Brazell, T., Durugkar, K. A., Maki, J. L., Ramana, C. V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004522107 · Cited by 138
Molecular subtypes and precision treatment of triple-negative breast cancer
Zhao, S., Zuo, W., Shao, Z., & Jiang, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.194 · Cited by 140
Phospholipase D Couples Survival and Migration Signals in Stress Response of Human Cancer Cells
Yang, Z., Rodrik-Outmezguine, V. S., Toschi, A., Shi, M., Li, H., Shen, Y., & Foster, D. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600660200 · Cited by 137
Joo, J. H., Yoo, H. J., Hwang, I., Lee, J. S., Nam, K. H., & Bae, Y. S. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.018 · Cited by 136
Strassheim, D., Asehnoune, K., Park, J.-S., Kim, J. Y., He, Q., Richter, D., Kuhn, K., Mitra, S., & Abraham, E. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5727 · Cited by 141
Intracellular Signaling Pathways Regulating Pluripotency of Embryonic Stem Cells
Okita, K., & Yamanaka, S. (2006) · Current Stem Cell Research & Therapy · doi:10.2174/157488806775269061 · Cited by 139
Sutherlin, D. P., Sampath, D., Berry, M., Castanedo, G. M., Chang, Z., Chuckowree, I., Dotson, J., Folkes, A. J., Friedman, L. S., Goldsmith, R. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901284w · Cited by 135
Sema4D/plexin‐B1 activates GSK‐3β through R‐Ras GAP activity, inducing growth cone collapse
Ito, Y., Oinuma, I., Katoh, H., Kaibuchi, K., & Negishi, M. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400737 · Cited by 139
Weigand, M., Hantel, P., Kreienberg, R., & Waltenberger, J. L. (2005) · Angiogenesis · doi:10.1007/s10456-005-9010-0 · Cited by 135
Guo, J., Wenk, M. R., Pellegrini, L., Onofri, F., Benfenati, F., & Camilli, P. V. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230488100 · Cited by 136
Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas
Mizoguchi, M., Nutt, C. L., Mohapatra, G., & Louis, D. N. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00080.x · Cited by 135
Ehrbrecht, A., Müller, U., Wolter, M., Hoischen, A., Koch, A., Radlwimmer, B., Actor, B., Mincheva, A., Pietsch, T., Lichter, P., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1925 · Cited by 135
Szymonowicz, K., Oeck, S., Malewicz, N. M., & Jendrossek, V. (2018) · Cancers · doi:10.3390/cancers10030078 · Cited by 135
Oxidative Stress in Methylmercury-Induced Cell Toxicity
dos Santos, A. A., Ferrer, B., Gonçalves, F. M., Tsatsakis, A. M., Renieri, E. A., Skalny, A. V., Farina, M., da Rocha, J. B. T., & Aschner, M. (2018) · Toxics · doi:10.3390/toxics6030047 · Cited by 136
Mitochondrial Calcium Regulation of Redox Signaling in Cancer
Delierneux, C., Kouba, S., Shanmughapriya, S., Potier‐Cartereau, M., Trebak, M., & Hempel, N. (2020) · Cells · doi:10.3390/cells9020432 · Cited by 138
The relative role of PLCβ and PI3Kγ in platelet activation
Lian, L., Wang, Y., Draznin, J., Eslin, D. E., BENNETT, J. S., Poncz, M., Wu, D., & Abrams, C. S. (2005) · Blood · doi:10.1182/blood-2004-05-2005 · Cited by 134
Frey, R. S., Gao, X., Javaid, K., Siddiqui, S. S., Rahman, A., & Malik, A. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508810200 · Cited by 134
REGULATION OF PHOSPHOLIPASE C ISOZYMES BY RAS SUPERFAMILY GTPASES
Harden, T. K., & Sondek, J. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141223 · Cited by 133
Role of Bax in quercetin-induced apoptosis in human prostate cancer cells
Lee, D., Szczepański, M. J., & Lee, Y. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.013 · Cited by 133
The Pathophysiology of Septic Shock
Nduka, O. O., & Parrillo, J. E. (2009) · Critical Care Clinics · doi:10.1016/j.ccc.2009.08.002 · Cited by 134
Pazini, F. L., Cunha, M. P., Rosa, J. M., Colla, A. R. D. S., Lieberknecht, V., Oliveira‐Giacomelli, Á., & Rodrigues, A. L. S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9580-9 · Cited by 135
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
Le, X., Antony, R., Razavi, P., Treacy, D. J., Luo, F., Ghandi, M., Castel, P., Scaltriti, M., Baselga, J. M., & Garraway, L. A. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0305 · Cited by 135
Arthur, D. E., & Uzairu, A. (2019) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2019.01.011 · Cited by 132
Delivery of drugs and macromolecules to the mitochondria for cancer therapy
Lu, P., Bruno, B. J., Rabenau, M., & Lim, C. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.023 · Cited by 133
AKT Signaling in Physiology and Disease
Vasudevan, K. M., & Garraway, L. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_66 · Cited by 135
Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis
Ihn, H. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.014 · Cited by 132
Regulation of chemotaxis by the orchestrated activation of Ras, PI3K, and TOR
Sasaki, A. T., & Firtel, R. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.04.007 · Cited by 133
Negative Regulation of AKT Activation by BRCA1
Tao, X., Ohashi, A., Huang, Y., Pandita, T. K., Ludwig, T., Powell, S. N., & Yang, Q. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3009 · Cited by 134
Dou, Z., Pan, J.-A., Dbouk, H. A., Ballou, L. M., DeLeon, J. L., Fan, Y., Chen, J.-S., Liang, Z., Li, G., Backer, J., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.022 · Cited by 134
Inositol pyrophosphates: Why so many phosphates?
Shears, S. B. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.09.015 · Cited by 130
TGF-β1 Protects against Mesangial Cell Apoptosis via Induction of Autophagy
Ding, Y., Kim, J. K., Kim, S. I., Na, H.-J., Jun, S. Y., Lee, S., & Choi, M. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093724 · Cited by 130
Current clinical development of PI3K pathway inhibitors in glioblastoma
Wen, P. Y., Lee, E. Q., Reardon, D. A., Ligon, K. L., & Yung, W. K. A. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos117 · Cited by 133
Joshi, S., Singh, A. R., Zulcic, M., & Durden, D. L. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0682 · Cited by 130
The PI3K, Metabolic, and Autophagy Networks: Interactive Partners in Cellular Health and Disease
Shanware, N. P., Bray, K., & Abraham, R. T. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134717 · Cited by 136
Choi, S., Hedman, A. C., Sayedyahossein, S., Thapa, N., Sacks, D. B., & Anderson, R. A. (2016) · Nature Cell Biology · doi:10.1038/ncb3441 · Cited by 132
Akt: a key transducer in cancer
Tsai, P., Lai, Y., Manne, R., Tsai, Y.-S., Sarbassov, D. D., & Lin, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00860-9 · Cited by 138
Sarkissian, M., Méndez, R., & Richter, J. D. (2004) · Genes & Development · doi:10.1101/gad.1136004 · Cited by 134
Metadata
- Authors
- Cantley, L. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Cantley, Lewis C.
- ORCID
- Cantley, Lewis C.
- Venue
- Science
- Published
- 2002-05-31
- Volume
- 296
- Issue
- 5573
- Pages
- 1655-1657
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2070732456
- Cited by
- 5,621
- References
- 9
- Citations by year
- 2026: 87 · 2025: 137 · 2024: 134 · 2023: 182 · 2022: 200 · 2021: 203 · 2020: 216 · 2019: 215 · 2018: 232 · 2017: 276 · 2016: 243 · 2015: 297 · 2014: 292 · 2013: 306 · 2012: 325
- FWCI
- 76.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM041890)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- phosphatidylinositol 3-kinase, PI3K signaling, phosphatidylinositol 3,4,5-trisphosphate, cell survival signaling, gene expression regulation, cellular metabolism, cytoskeletal rearrangement, diabetes mellitus, cancer, therapeutic target
- MeSH terms
- Animals, Cell Membrane, Cell Physiological Phenomena, Diabetes Mellitus, Type 2, Humans, Models, Biological, Neoplasms, Phosphorylation, Protein Kinases, Proto-Oncogene Proteins, Signal Transduction, Protein Serine-Threonine Kinases, Phosphatidylinositol Phosphates, Phosphatidylinositol 4,5-Diphosphate, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review